Medication info
Myungmoon Rosuvastatin Calcium Tablet 20 Milligrams

Myungmoon Rosuvastatin Calcium Tablet 20 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
For domestic use: 30 tablets/bottle, for export: 30 tablets/box (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201400004 · Approved 2014.01.02 · Insurance code 649806410

Summary

Main use
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
Who takes it
Adults
Adult dose
1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Assessment of renal function should be considered in these patients. There is no experience with use in patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease

  • Primary hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • primary dysbetalipoproteinemia
  • coronary heart disease
  • hypertension
  • low HDL-cholesterol levels
  • smoking
  • family history of early coronary heart disease
  • stroke
  • myocardial infarction
View approved original text

This medication is used as an adjunct in patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise are insufficient. It also helps patients with homozygous familial hypercholesterolemia as an adjunct to diet or other lipid-lowering therapies. It effectively lowers total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis. It is also used as an adjunct to diet in patients with primary dysbetalipoproteinemia. Furthermore, it is used to reduce the risk of stroke, myocardial infarction, and arterial revascularization in high-risk patients with cardiovascular disease risk factors above a certain threshold. Therefore, this medication is effective in improving lipid levels and reducing cardiovascular disease risk.

How to take

Adult dose

1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Assessment of renal function should be considered in these patients. There is no experience with use in patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Precautions

This medication should not be used in certain patients. It should not be administered to patients with an allergy to this medication, unexplained liver dysfunction, muscular disorders, those taking cyclosporine, patients with severe renal dysfunction, pregnant or nursing women, and fertile women who are not using appropriate contraception. Additionally, high doses are prohibited in patients at high risk for muscular disorders, and those with certain genetic problems such as lactose intolerance should also avoid this medication. This medication should be used with caution in patients who consume a lot of alcohol or have a history of liver disease, and liver function tests should be repeated before and during treatment. If symptoms such as muscle pain or weakness occur, the patient should immediately consult a physician, and patients at high risk for muscle damage should have their muscle enzyme levels checked regularly. This medication should be discontinued if severe health conditions or acute renal function deterioration is anticipated. This medication can rarely cause severe muscle weakness or ophthalmoplegia; if these symptoms occur, the medication should be stopped. Combining this medication with certain specific drugs may increase the risk of muscle damage; therefore, it is advisable to consult a physician before combining medications, and it is recommended not to combine with some drugs. High doses may cause temporary proteinuria, necessitating renal function tests. In Asians, drug concentrations may increase, so dosage adjustments may be necessary. In pediatric and adolescent patients, usage is recommended only for a limited period, and monitoring of growth and maturation is required. During the use of this medication, rare adverse effects may occur, such as liver damage, skin reactions, neurological abnormalities, gastrointestinal disturbances, and muscle-related adverse reactions, so any symptoms should be immediately reported to medical staff. Women who are pregnant or potentially pregnant must ensure appropriate contraception, and the use of this medication should be immediately stopped if pregnancy occurs. In case of overdose, there is no specific antidote, so symptomatic treatment and liver and muscle function tests are needed. This medication is known to have little effect on driving or operating machinery, but caution is advised as dizziness may occur. The effects and side effects of this medication can vary from individual to individual; therefore, if there are any suspected symptoms or unusual reactions during use, consultation with a professional is essential.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ophthalmoplegic myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, erythrodermic drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius. Storing it this way helps maintain the efficacy and safety of the medication for an extended period.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

For domestic use: 30 tablets/bottle, for export: 30 tablets/box (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.